On December 20, 2024, Oluyemi Okupe, the Chief Financial Officer of Hims & Hers Health Inc (HIMS, Financial), sold 18,959 shares of the company, according to a SEC Filing. Following this transaction, the insider now owns 132,578 shares of the company.
Hims & Hers Health Inc is a telehealth company that provides a range of health and wellness products and services. The company focuses on offering accessible and affordable care through its digital platform, which connects consumers with licensed healthcare professionals.
Over the past year, Oluyemi Okupe has sold a total of 784,282 shares and has not purchased any shares. The insider transaction history for Hims & Hers Health Inc shows that there have been 2 insider buys and 105 insider sells over the same timeframe.
On the day of the recent sale, shares of Hims & Hers Health Inc were trading at $25.77, giving the stock a market cap of $6.03 billion. The company's price-earnings ratio is 62.73, which is higher than the industry median of 17.9 but lower than the company’s historical median price-earnings ratio.
With a price of $25.77 and a GuruFocus Value of $18.69, Hims & Hers Health Inc has a price-to-GF-Value ratio of 1.38, indicating that the stock is significantly overvalued based on its GF Value. The GF Value is an intrinsic value estimate developed by GuruFocus, calculated based on historical multiples, a GuruFocus adjustment factor, and future estimates of business performance from Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
